Glyco-Engineering of Moss Lacking Plant-Specific Sugar Residues

Abstract

The commercial production of complex pharmaceutical proteins from human origin in plants is currently limited through differences in protein N-glycosylation pattern between plants and humans. On the one hand, plant-specific α(1,3)-fucose and β(1,2)-xylose residues were shown to bear strong immunogenic potential. On the other hand, terminal β(1,4)-galactose, a sugar common on N-glycans of pharmaceutically relevant proteins, e.g., antibodies, is missing in plant N-glycan structures. For safe and flexible production of pharmaceutical proteins, the humanisation of plant protein N-glycosylation is essential. Here, we present an approach that combines avoidance of plant-specific and introduction of human glycan structures. Transgenic strains of the moss Physcomitrella patens were created in which the α(1,3)-fucosyltransferase and β(1,2)-xylosyltransferase genes were knocked out by targeted insertion of the human β(1,4)-galactosyltransferase coding sequence in both of the plant genes (knockin). The transgenics lacked α(1,3)-fucose and β(1,2)-xylose residues, whereas β(1,4)-galactose residues appeared on protein N-glycans. Despite these significant biochemical changes, the plants did not differ from wild type with regard to overall morphology under standard cultivation conditions. Furthermore, the glyco-engineered plants secreted a transiently expressed recombinant human protein, the vascular endothelial growth factor, in the same concentration as unmodified moss, indicating that the performed changes in glycosylation did not impair the secretory pathway of the moss. The combined knockout/knockin approach presented here, leads to a new generation of engineered moss and towards the safe and flexible production of correctly processed pharmaceutical proteins with humanised N-glycosylation profiles.

N-glycosylation - gene knockout - glyco-engineering - Physcomitrella patens - complex biopharmaceuticals - VEGF

References

• 1 Bakker H.. et al. . Galactose-extended glycans of antibodies produced by transgenic plants.  Proceedings of the National Academy of Sciences of the USA. (2001);  98 2899-2904
• 2 Bardor M., Faveeuw C., Fitchette A. C., Gilbert D., Galas L., Trottein F., Faye L., Lerouge P.. Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose.  Glycobiology. (2003);  13 427-434
• 3 Bierfreund N. M., Reski R., Decker E. L.. Use of an inducible reporter gene system for the analysis of auxin distribution in the moss Physcomitrella patens. .  Plant Cell Reports. (2003);  21 1143-1152
• 4 Decker E. L., Reski R.. The moss bioreactor.  Current Opinion in Plant Biology. (2004);  7 166-170
• 5 Faye L., Gomord V., Fitchette-Laine A. C., Chrispeels M. J.. Affinity purification of antibodies specific for Asn-linked glycans containing alpha 1,3 fucose or beta 1,2 xylose.  Analytical Biochemistry. (1993);  209 104-108
• 6 Fischer R., Stoger E., Schillberg S., Christou P., Twyman R. M.. Plant-based production of biopharmaceuticals.  Current Opinion in Plant Biology. (2004);  7 152-158
• 7 Foetisch K., Westphal S., Lauer I., Retzek M., Altmann F., Kolarich D., Scheurer S., Vieths S.. Biological activity of IgE specific for cross-reactive carbohydrate determinants.  Journal of Allergy and Clinical Immunology. (2003);  111 889-896
• 8 Garcia-Casado G., Sanchez-Monge R., Chrispeels M. J., Armentia A., Salcedo G., Gomez L.. Role of complex asparagine-linked glycans in the allergenicity of plant glycoproteins.  Glycobiology. (1996);  6 471-477
• 9 Girke T., Schmidt H., Zahringer U., Reski R., Heinz E.. Identification of a novel delta 6-acyl-group desaturase by targeted gene disruption in Physcomitrella patens.  Plant Journal. (1998);  15 39-48
• 10 Gomord V., Faye L.. Posttranslational modification of therapeutic proteins in plants.  Current Opinion in Plant Biology. (2004);  7 171-181
• 11 Gomord V., Sourrouille C., Fitchette A. C., Bardor M., Pagny S., Lerouge P., Faye L.. Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge.  Plant Biotechnology Journal. (2004);  2 83-100
• 12 Hohe A., Decker E. L., Gorr G., Schween G., Reski R.. Tight control of growth and cell diffentiation in photoautotropically growing moss Physcomitrella patens bioreactor cultures.  Plant Cell Reports. (2002);  20 1135-1140
• 13 Hohe A., Reski R.. Optimisation of a bioreactor culture of the moss Physcomitrella patens for mass production of protoplasts.  Plant Science. (2002);  163 69-74
• 14 Holtorf H., Guitton M. C., Reski R.. Plant functional genomics.  Naturwissenschaften. (2002);  89 235-249
• 15 Hood E. E., Woodard S. L., Horn M. E.. Monoclonal antibody manufacturing in transgenic plants - myths and realities.  Current Opinion in Biotechnololgy. (2002);  13 630-635
• 16 Jost W., Link S., Horstmann V., Decker E. L., Reski R., Gorr G.. Isolation and characterisation of three moss-derived beta-tubulin promoters suitable for recombinant expression.  Current Genetics. (2005);  47 111-120
• 17 Ko K.. et al. . Function and glycosylation of plant-derived antiviral monoclonal antibody.  Proceedings of the National Academy of Sciences of the USA. (2003);  100 8013-8018
• 18 Koprivova A., Altmann F., Gorr G., Kopriva S., Reski R., Decker E. L.. N-glycosylation in the moss Physcomitrella patens is organized similarly to higher plants.  Plant Biology. (2003);  5 582-591
• 19 Koprivova A., Stemmer C., Altmann F., Hoffmann A., Kopriva S., Gorr G., Reski R., Decker E. L.. Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans.  Plant Biotechnology Journal. (2004);  2 517-523
• 20 Lisowska E.. The role of glycosylation in protein antigenic properties.  Cellular and Molecular Life Sciences. (2002);  59 445-455
• 21 Lorenz S., Tintelnot S., Reski R., Decker E. L.. Cyclin D-knockout uncouples developmental progression from sugar availability.  Plant Molecular Biology. (2003);  53 227-236
• 22 Ma J. K., Drake P. M., Christou P.. The production of recombinant pharmaceutical proteins in plants.  Nature Reviews Genetics. (2003);  4 794-805
• 23 Obermeyer G., Gehwolf R., Sebesta W., Hamilton N., Gadermaier G., Ferreira F., Commandeur U., Fischer R., Bentrup F. W.. Over-expression and production of plant allergens by molecular farming strategies.  Methods. (2004);  32 235-240
• 24 Palacpac N. Q., Yoshida S., Sakai H., Kimura Y., Fujiyama K., Yoshida T., Seki T.. Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns.  Proceedings of the National Academy of Sciences of the USA. (1999);  96 4692-4697
• 25 Raskin I.. et al. . Plants and human health in the twenty-first century.  Trends in Biotechnology. (2002);  20 522-531
• 26 Reski R., Abel W. O.. Induction of budding on chloronema and caulonema of the moss, Physcomitrella patens, using isopentenyladenine.  Planta. (1985);  165 354-358
• 27 Schaefer D. G.. A new moss genetics: targeted mutagenesis in Physcomitrella patens. .  Annual Review of Plant Biology. (2002);  53 477-501
• 28 Schillberg S., Fischer R., Emans N.. “Molecular farming” of antibodies in plants.  Naturwissenschaften. (2003);  90 145-155
• 29 Schween G., Fleig S., Reski R.. High-throughput-PCR screen of 15 000 transgenic Physcomitrella plants.  Plant Molecular Biology Reporter. (2002);  20 1-5
• 30 Shields R. L., Lai J., Keck R., O'Connell L. Y., Hong K., Meng Y. G., Weikert S. H., Presta  G L.. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc-gamma RIII and antibody-dependent cellular toxicity.  Journal of Biological Chemistry. (2002);  277 26733-26740
• 31 Sriraman R., Bardor M., Sack M., Vaquero C., Faye L., Fischer R., Finnern R., Lerouge P.. Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core xylose and core-α(1,3)-fucose residues.  Plant Biotechnology Journal. (2004);  2 279-287
• 32 Strasser R., Altmann F., Mach L., Glössl J., Steinkellner H.. Generation of Arabidopsis thaliana plants with complex N-glycans lacking β1,2-linked xylose and core α1,3-linked fucose.  FEBS Letters. (2004);  561 132-136
• 33 Tekoah Y., Ko K., Koprowski H., Harvey D. J., Wormald M. R., Dwek R. A., Rudd P. M.. Controlled glycosylation of therapeutic antibodies in plants.  Archives of Biochemistry and Biophysics. (2004);  426 266-278
• 34 Topfer R., Matzeit V., Gronenborn B., Schell J., Steinbiss H. H.. A set of plant expression vectors for transcriptional and translational fusions.  Nucleic Acids Research. (1987);  15 5890
• 35 Twyman R. M., Stoger E., Schillberg S., Christou P., Fischer R.. Molecular farming in plants: host systems and expression technology.  Trends in Biotechnology. (2003);  21 570-578
• 36 van Ree R.. et al. . Beta(1,2)-xylose and alpha(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens.  Journal of Biological Chemistry. (2000);  275 11451-11458
• 37 Vietor R., Loutelier-Bourhis C., Fitchette A. C., Margerie P., Gonneau M., Faye L., Lerouge P.. Protein N-glycosylation is similar in the moss Physcomitrella patens and in higher plants.  Planta. (2003);  218 269-275
• 38 Westphal S.. et al. . Molecular characterization and allergenic activity of Lyc e 2 (betafructofuranosidase), a glycosylated allergen of tomato.  European Journal of Biochemistry. (2003);  270 1327-1337
• 39 Wilson I. B., Zeleny R., Kolarich D., Staudacher E., Stroop C. J., Kamerling J. P., Altmann F.. Analysis of Asn-linked glycans from vegetable foodstuffs: widespread occurrence of Lewis a, core alpha1,3-linked fucose and xylose substitutions.  Glycobiology. (2001);  11 261-274
• 40 Wright A., Sato Y., Okada T., Chang K., Endo T., Morrison S.. In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure.  Glycobiology. (2000);  10 1347-1355
• 41 Zeng Y., Bannon G., Thomas V. H., Rice K., Drake R., Elbein A.. Purification and specificity of β1,2-xylosyltransferase, and enzyme that contributes to allergenicity of some plant proteins.  Journal of Biological Chemistry. (1997);  272 31340-31347

1 * Both authors have contributed equally to this work

Editor: H. Rennenberg